CB promotes the poly-ubiquitination of NRF2 by β-TrCP, which in turn suppresses the growth of KEAP1 mutant NSCLC lung cancer xenografts [200]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.